1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Eric Stephen Winer, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome BXCL701 - Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 | Phase 1 | Active not recruiting | Eric Stephen Winer, MD | 12 | 2023-02-02 | 2026-10-19 |
PT-100 dipeptide (1) · talabostat (1)
United States (1)